Yanfang Ding

866 total citations
24 papers, 713 citations indexed

About

Yanfang Ding is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Yanfang Ding has authored 24 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Biomaterials. Recurrent topics in Yanfang Ding's work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yanfang Ding is often cited by papers focused on MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Yanfang Ding collaborates with scholars based in China, Canada and United States. Yanfang Ding's co-authors include Changyuan Wang, Shiying Cui, Lei Li, Jing Zhao, Youwei Xu, Gordon Guo, Jinyao Zhao, Yutong Wang, Chun Peng and Xiaotang Yu and has published in prestigious journals such as Chemical Engineering Journal, Journal of Cell Science and Journal of Colloid and Interface Science.

In The Last Decade

Yanfang Ding

23 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfang Ding China 16 428 270 115 86 85 24 713
Qin He China 14 425 1.0× 219 0.8× 168 1.5× 110 1.3× 73 0.9× 21 734
Cristian Moldovan Romania 17 322 0.8× 179 0.7× 91 0.8× 94 1.1× 51 0.6× 53 854
Ravi Doddapaneni United States 21 503 1.2× 99 0.4× 189 1.6× 132 1.5× 177 2.1× 33 1.1k
Zeting Yuan China 18 411 1.0× 194 0.7× 238 2.1× 275 3.2× 86 1.0× 31 1.0k
Hui Li Ang Singapore 12 500 1.2× 245 0.9× 91 0.8× 70 0.8× 16 0.2× 13 862
Yijia Chen China 13 426 1.0× 166 0.6× 92 0.8× 28 0.3× 149 1.8× 24 707
Mohammed Sikander United States 12 347 0.8× 141 0.5× 85 0.7× 52 0.6× 25 0.3× 23 562
Ebrahim Rahmani Moghadam Iran 13 568 1.3× 319 1.2× 107 0.9× 94 1.1× 23 0.3× 18 946
Hongxia Duan China 10 230 0.5× 83 0.3× 170 1.5× 162 1.9× 52 0.6× 10 618
Mahdi Vasheghani Farahani Iran 8 383 0.9× 158 0.6× 107 0.9× 100 1.2× 18 0.2× 8 688

Countries citing papers authored by Yanfang Ding

Since Specialization
Citations

This map shows the geographic impact of Yanfang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfang Ding more than expected).

Fields of papers citing papers by Yanfang Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfang Ding. The network helps show where Yanfang Ding may publish in the future.

Co-authorship network of co-authors of Yanfang Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfang Ding. A scholar is included among the top collaborators of Yanfang Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfang Ding. Yanfang Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yanfang, Jingjing Qi, Peng Chu, et al.. (2025). Cascade-responsive nanoplatform for synergistic cancer therapy via ROS amplification and hypoxia targeting. Chemical Engineering Journal. 516. 164112–164112. 1 indexed citations
2.
Guo, Lina, Chuanzhou Gao, Kaiwen Chen, et al.. (2022). Development of Biomimetic Hepatic Lobule-Like Constructs on Silk-Collagen Composite Scaffolds for Liver Tissue Engineering. Frontiers in Bioengineering and Biotechnology. 10. 940634–940634. 7 indexed citations
3.
Chen, Lixue, Yanfang Ding, Changyuan Wang, et al.. (2022). Intelligent triggering of nanomicelles based on a ROS-activated anticancer prodrug and photodynamic therapy (PDT)-synergistic therapy for lung cancers. European Journal of Medicinal Chemistry. 241. 114622–114622. 18 indexed citations
4.
Chen, Lixue, Shengnan Li, Yanfang Ding, et al.. (2021). Honokiol Prodrug Nanoparticles Based on In Situ Albumin Binding for Long Circulation and High Tumor Uptake. ACS Medicinal Chemistry Letters. 12(10). 1589–1595. 9 indexed citations
5.
Yu, Xiaotang, Xinchen Zhang, Bo Wang, et al.. (2020). miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer. Cancer Cell International. 20(1). 534–534. 15 indexed citations
6.
Wang, Yutong, Yanfang Ding, Changyuan Wang, et al.. (2020). Fenretinide-polyethylene glycol (PEG) conjugate with improved solubility enhanced cytotoxicity to cancer cell and potent in vivo efficacy. Pharmaceutical Development and Technology. 25(8). 962–970. 6 indexed citations
7.
Wang, Yutong, Yanfang Ding, Youwei Xu, et al.. (2020). Mixed micelles of TPGS and Soluplus® for co-delivery of paclitaxel and fenretinide: in vitro and in vivo anticancer study. Pharmaceutical Development and Technology. 25(7). 865–873. 27 indexed citations
8.
Ding, Yanfang, Yingying Ding, Yutong Wang, et al.. (2019). Soluplus ® /TPGS mixed micelles for co-delivery of docetaxel and piperine for combination cancer therapy. Pharmaceutical Development and Technology. 25(1). 107–115. 30 indexed citations
9.
Ding, Yanfang, Wei Liu, Weiting Yu, et al.. (2018). Three-dimensional tissue culture model of human breast cancer for the evaluation of multidrug resistance. Journal of Tissue Engineering and Regenerative Medicine. 12(9). 1959–1971. 22 indexed citations
10.
Ding, Yingying, Changyuan Wang, Yutong Wang, et al.. (2018). Development and evaluation of a novel drug delivery: Soluplus®/TPGS mixed micelles loaded with piperine in vitro and in vivo. Drug Development and Industrial Pharmacy. 44(9). 1409–1416. 53 indexed citations
11.
Zhao, Jing, Youwei Xu, Changyuan Wang, et al.. (2017). Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy. Drug Development and Industrial Pharmacy. 43(7). 1197–1204. 59 indexed citations
12.
Zhao, Henan, Xiaotang Yu, Yanfang Ding, et al.. (2016). MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. PMC. 1 indexed citations
13.
Wang, Yutong, Changyuan Wang, Jing Zhao, Yanfang Ding, & Lei Li. (2016). A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability. Journal of Colloid and Interface Science. 485. 91–98. 89 indexed citations
14.
Zhang, Xinchen, Gordon Guo, Jinyao Zhao, et al.. (2015). Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma. Molecular Medicine Reports. 12(6). 8021–8031. 23 indexed citations
15.
Zhao, Henan, Sha Liu, Guang Wang, et al.. (2014). Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer. Oncology Reports. 33(2). 591–598. 53 indexed citations
16.
Zhao, Henan, et al.. (2013). miRNA expression pattern associated with prognosis in elderly patients with advanced OPSC and OCC. International Journal of Oncology. 43(3). 839–849. 16 indexed citations
17.
Yu, Xiaotang, Xinchen Zhang, Yanfang Ding, et al.. (2013). MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma. Tumor Biology. 34(6). 3501–3508. 48 indexed citations
18.
Zhao, Jinyao, Chunqing Liu, Henan Zhao, et al.. (2012). Synchronous detection of miRNAs, their targets and downstream proteins in transferred FFPE sections: Applications in clinical and basic research. Methods. 58(2). 156–163. 4 indexed citations
19.
Fu, Guodong, Shiying Cui, Stefanie Bernaudo, et al.. (2011). MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. Journal of Cell Science. 124(3). 359–368. 114 indexed citations
20.
Wang, Jianfeng, Haiying Chu, Hua Zhao, et al.. (2007). Nitricoxide synthase-induced oxidative stress in prolonged alcoholic myopathies of rats. Molecular and Cellular Biochemistry. 304(1-2). 135–142. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qin He Breakdown of academic impact, for papers by Cristian Moldovan Breakdown of academic impact, for papers by Ravi Doddapaneni Breakdown of academic impact, for papers by Zeting Yuan Breakdown of academic impact, for papers by Hui Li Ang Breakdown of academic impact, for papers by Yijia Chen Breakdown of academic impact, for papers by Mohammed Sikander Breakdown of academic impact, for papers by Ebrahim Rahmani Moghadam Breakdown of academic impact, for papers by Hongxia Duan Breakdown of academic impact, for papers by Mahdi Vasheghani Farahani
Rankless by CCL
2026